Form 8-K - Current report:
SEC Accession No. 0001437749-17-009778
Filing Date
2017-05-22
Accepted
2017-05-22 14:41:34
Documents
2
Period of Report
2017-05-18
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K atrn20170522_8k.htm 8-K 33996
2 EXHIBIT 16.1 ex16-1.htm EX-16.1 4708
  Complete submission text file 0001437749-17-009778.txt   40119
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51353 | Film No.: 17860604
SIC: 7389 Services-Business Services, NEC